Sea Water Nasal Spray Market is expected to reach US$ 3,812.22 million by 2030

Hypertonic Sea Water Nasal Spray Segment to Lead Sea Water Nasal Spray Market Based on Type During 2022–2030

According to our new research study on “Sea Water Nasal Spray Market Forecast to 2030 – Global Analysis – Type, Application, and Geography,” the sea water nasal spray market size was valued at US$ 2,446.42 million in 2022 to US$ 3,812.22 million by 2030; it is estimated to record a CAGR of 5.7% during 2022–2030. Key factors driving the sea water nasal spray market are the increase in infection and allergic cases and a rise in patient preference for nasal drug delivery due to easy administration and better efficacy. However, regulatory hurdles restrain the market growth.

Nasal sprays help deliver the drug through the nose in the nasal cavity to treat allergies and other problems related to brain inflammation, diabetes, dental problems, and the central nervous system. Allergy is a condition in which the body's immune system reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients.

Sea Water Nasal Spray Market, by Region, 2022(%)

Source: The Insight Partners Analysis

Different types of nasal sprays are available in the market, such as decongestion nasal spray, saline nasal spray, and steroid nasal spray. Decongestants are devices with drugs for treating nasal congestion and providing short-term relief from a blocked nose. Decongestion nasal sprays consist of drugs that open up the airways of the nasal part and help in the breathing process.

During the cold and dry winter season, saline nasal sprays are used to avoid problems related to a stuffy nose. These devices are used to treat sinusitis, nasal crusting, and thin secretions of liquid from the nose, which are formed due to bacterial infection and lead to the dryness of the nasal area. This device helps clean the nasal passage and mucus in that area due to cold.

Nasal hygiene can be maintained by regular irrigation using saline solutions, which help eliminate excess secretions, pollutants, pathogens, and allergens accumulating in the nasal cavity, reduce congestion, and moisturize the nose. Utilization of saline solutions for nasal irrigation is easy to use, well tolerated, and effective for nasal hygiene. For example, in children, saline nasal irrigation has been shown to re-establish the nasal permeability of post-rhinitis and prevent the recurrence of cold and flu and nasal congestion. Another clinical trial in children with allergic rhinitis has concluded that nasal saline irrigation may be a good adjunctive treatment option. Using nasal irrigation decreases the use of topical steroids for controlling allergic rhinitis in children, which may eventually lessen the condition's side effects and economic burden. Indeed, nasal irrigation with saline solutions is recommended as an adjunct therapy for the common cold, acute and chronic rhinosinusitis, and allergic rhinitis, alleviating sinonasal symptoms.

Saline solutions can be obtained by diluting seawater and used for nasal irrigation at isotonic concentration (0.9% NaCl), equal to Na+ and Cl− ions in the human body. Early in the twentieth century, microfiltered diluted ocean water (or “marine plasma”) was shown to have an identical ionic balance to blood serum and interstitial fluid. In addition to sodium and chloride, diluted seawater contains the full spectrum of minerals and trace elements in human plasma, such as potassium, calcium, and magnesium. Studies have demonstrated the beneficial role of diluted seawater over classic saline solution preparations for nasal irrigation.

Due to the advantages of nasal sprays, pharmaceutical and biotechnology companies have increased their investment in research and development to develop new nasal spray products to treat diseases such as infectious diseases or CNS disorders. For instance, in March 2023, Pfizer received FDA approval for Zavzpret, a nasal spray used to treat migraines. In March 2019, Janssen Pharmaceuticals Sparvato (ketamine) got FDA approval. It is a nasal spray used by adult patients with treatment-resistant depression. Thus, pharmaceutical companies increasingly focus on developing new nasal spray products to treat various diseases. Improved healthcare infrastructure, increased healthcare expenditures, and R&D funding will propel the market growth.

The sea water nasal spray market, based on type, is segmented into isotonic sea water nasal spray, hypertonic sea water nasal spray, and hypotonic sea water nasal spray. In 2022, the hypertonic sea water nasal spray segment held the largest share of the market and is anticipated to register the highest CAGR in the market from 2022 to 2030. Physicians recommend hypertonic nasal spray due to the higher concentration of salt that may draw fluid and mucus out more effectively. Hypertonic sea water nasal spray soothes nasal congestion during bacterial and viral infections, sinusitis, and colds. It helps clear the nose of excessive secretions. Saline nasal spray moisturizes and soothes dried-up mucus membranes caused by staying in air-conditioned or overheated rooms. Thus, these advantages are expected to propel the demand for hypertonic sea water nasal sprays, thereby positively impacting the sea water nasal spray market.

Sterimar, LABORATOIRE DE LA MER, Gerolymatos International, Humer, Gifrer, GSK, Nacur Healthcare, Laboratoires Pharmaster, Bayer, and Sandoz are among the leading companies operating in the sea water nasal spray market.  

The sea water nasal spray market is classified into type, application, and geography. Based on type, the sea water nasal spray market is categorized into isotonic sea water nasal spray, hypertonic sea water nasal spray, and hypotonic sea water nasal spray. The sea water nasal spray market, based on application, is segmented into infants, children, and adults. The sea water nasal spray market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com